• Company
• KRW 15M incentive to employees assigned to Organon
• by Jan 25, 2021 06:21am

• Company
• Evenity can be prescribed at general hospitals
• by Eo, Yun-Ho Jan 25, 2021 06:21am

• Company
• KanghanLaw scouted Adviser Jaehong Kwon from BMS Korea
• by Eo, Yun-Ho Jan 25, 2021 06:21am

• Company
• ↑sales of chronic disease drugs & ↓sales of antibiotics
• by Chon, Seung-Hyun Jan 22, 2021 06:28am

• Company
• The sales of flu treatment fell 99.6% due to COVID-19
• by Chon, Seung-Hyun Jan 22, 2021 06:26am

• Company
• Pharmaceutical industry rushes to recruit new GA managers
• by Eo, Yun-Ho Jan 22, 2021 06:26am

• Company
• Viatris·Organon's prescription performance declined
• by Kim, Jin-Gu Jan 22, 2021 06:26am

• Product
• Efficacy vs. More inoculation? Vaccination plan in dilemma
• by Choi-sun Jan 22, 2021 06:26am

• Company
• Takeda to retry expanding all-comer coverage on Zejula
• by Eo, Yun-Ho Jan 21, 2021 06:15am

• Policy
• GemVax dementia drug candidate is reviewed for PSP
• by Lee, Tak-Sun Jan 21, 2021 06:14am